NASDAQ Gainers: Apple Inc. (NASDAQ:AAPL), Cesca Therapeutics Inc (NASDAQ:KOOL), Canadian Solar Inc. (NASDAQ:CSIQ), Cytokinetics, Inc. (NASDAQ:CYTK)

Apple Inc. (NASDAQ:AAPL) has long been a trend-setter whose hot products attract imitators, and now its recent stock split might help revive a trend from the 1990s that has all but disappeared on Wall Street. On Wednesday, the iPad maker and largest U.S. company by market value said it would do a seven-for-one split, knocking its share price down from the $500-plus level to something closer to $75. Apple Inc. (NASDAQ:AAPL) stock performance was 8.20% in last session and finished the day at $567.77. Traded volume was 27.14million shares in the last session and the average volume of the stock remained 10.60million shares. The beta of the stock remained 1.01. Apple Inc. (NASDAQ:AAPL) insider ownership is 0.04%.

Nano cap Cesca Therapeutics Inc (NASDAQ:KOOL) shows bullish price action with today’s up move on a 10x surge in volume. It represents a successful retest of the January 21 breakout when prices popped 111% on massive turnover of 32.9M shares after the company announced positive Phase 1b clinical trial results for its stem cell therapy for critical limb ischemia. Cesca Therapeutics Inc (NASDAQ:KOOL) rose 28.75 percent to $2.06 Thursday on volume of 9.41million shares. The intra-day range of the stock was $1.76 to $2.19. Cesca Therapeutics Inc (NASDAQ:KOOL) has a market capitalization of $67.18million.

Other stocks worth considering in the solar industry include Canadian Solar Inc. (NASDAQ:CSIQ), sporting a Zacks Rank #1 (Strong Buy). Canadian Solar Inc. (NASDAQ:CSIQ)’s stock on Apr 24, 2014 reported a increase of 5.10% to the closing price of $30.70. Its fifty two weeks range is $4.25 -$44.50. The total market capitalization recorded $1.66billion. The overall volume in the last trading session was 4.39million shares. In its share capital, CSIQ has 54.23million outstanding shares.

Cytokinetics, Inc. (NASDAQ:CYTK) announced that it is scheduled to report first quarter results on Tuesday, May 6, 2014 at 4:00 PM Eastern Time. Following the announcement, Cytokinetics Inc. (NASDAQ:CYTK)’s senior management will host a conference call at 4:30 PM Eastern Time to discuss operational and financial results and the company’s outlook for the future. On Thursday, shares of Cytokinetics, Inc. (NASDAQ:CYTK) advanced 8.98% to close the day at $12.99. Company return on investment (ROI) is -62.30% and its monthly performance is recorded as 44.65%. Cytokinetics, Inc. (NASDAQ:CYTK) quarterly revenue growth is 44.01%.

Signup for free to be the first to receive exclusive free links. Now in your mailbox!
Join over 15,000 subscribers
Send me links

Your information will not be shared to anyone